US FDA Orders New Eye Risk Warnings For Ozempic And Zepbound
· World · Reuters, CNN, Financial Times
The US Food and Drug Administration has mandated new eye risk warnings for the diabetes and weight-loss drugs Ozempic and Zepbound, as reported by Reuters and CNN. The warning specifically addresses potential vision problems, including rare cases of blindness, associated with the medications. These updated safety alerts require pharmaceutical companies to include detailed information about the eye-related risks in patient information sheets and prescribing information. The FDA's action follows ongoing monitoring of the drugs' safety profile since their market approval.
Why it matters
Diabetes and obesity patients in India and globally must now be explicitly informed about the potential for serious eye damage when using these widely prescribed drugs, prompting closer monitoring by healthcare providers.
Read the original report — Reuters
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.